« Back to Record
Citation APA

Chuang, W. L., Hu, T. H., Buggisch, P., Moreno, C., Su, W. W., Biancone, L., Camargo, M., Hyland, R. R., Lu, S., Kirby, B. B., Dvory-Sobol, H., Osinusi, A. A., Gaggar, A., Peng, C. Y., Liu, C. H., Sise, M. M., & Mangia, A. (2021). Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease. The American journal of gastroenterology, 116(9), 1924-1928. doi:10.14309/ajg.0000000000001281


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/332386

Chuang, W. L., Hu, T. H., Buggisch, P., Moreno, C., Su, W. W., Biancone, L., Camargo, M., Hyland, R. R., Lu, S., Kirby, B. B., Dvory-Sobol, H., Osinusi, A. A., Gaggar, A., Peng, C. Y., Liu, C. H., Sise, M. M., & Mangia, A. (2021). Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease. The American journal of gastroenterology, 116(9), 1924-1928. doi:10.14309/ajg.0000000000001281